42 Amendments of Fredrick FEDERLEY related to 2017/2254(INI)
Amendment 3 #
Motion for a resolution
Citation 9 a (new)
Citation 9 a (new)
– having regard to the European Parliament resolution of 26 November 2015 on a new animal welfare strategy for 2016-2020,
Amendment 17 #
Motion for a resolution
Recital A
Recital A
A. whereas the excessive and inappropriatecorrect use of antibiotics and poor infection control practices in both human and veterinary medicine have progressively rendered antimicrobial resistance (AMR) a massive threat to humankind;
Amendment 20 #
Draft opinion
Paragraph 2
Paragraph 2
2. Calls on the Commission and the Member States to take an ambitious and leading approach to ensuring that the targets set out in their respective Action Plans are fully and effectively achieved, and to strictly monitor the results that have been achieved;
Amendment 25 #
Draft opinion
Recital C a (new)
Recital C a (new)
Ca. whereas the Commission has committed to invest more than EUR 200 million in AMR for the last 3 years of Horizon 2020;
Amendment 31 #
Draft opinion
Paragraph 1
Paragraph 1
1. Emphasises the need to increase funding for R&I in epidemiology and different treatments in immunology for AMR pathogens and healthcare-associated infections (HAI);
Amendment 35 #
Motion for a resolution
Recital B
Recital B
B. whereas the misincorrect use of antibiotics is eroding their efficacy and leading to the spread of highly resistant bacteria that are especially resistant to last- line antibiotics; whereas according to data provided by the OECD, an estimated 700 000 deaths worldwide may be caused by AMR every year;
Amendment 36 #
Draft opinion
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Urges the need to enable antimicrobial stewardship in order to improve evidence-based prescribing;
Amendment 37 #
Draft opinion
Paragraph 3
Paragraph 3
3. Calls for legislative solutions that will assist farmers in reducing the use of antibiotics in livestock farming, with the aim of prudent and responsible use of antimicrobials; insists that such legislative solutions must address prophylactic and metaphylactic use; endeavours to keep the additional administrative burden as small as possible;
Amendment 44 #
Draft opinion
Paragraph 1 c (new)
Paragraph 1 c (new)
1c. Underlines the need to invest in research and innovation dedicated to improvement of vaccination in order to support prevention;
Amendment 53 #
Draft opinion
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Underlines the importance of identifying and addressing specific access, market sustainability and supply bottlenecks for existing antibiotics, diagnostics and vaccines, and the development of innovative financing and procurement mechanisms to resolve them;
Amendment 58 #
Draft opinion
Paragraph 4
Paragraph 4
4. Calls for further research and development into new antimicrobials and encourages alternatives, such as vaccines, to be investigated, including the development of more sustainable farming systems based on less intensive farming modelsand animal friendly farming models to ensure adequate animal husbandry;
Amendment 63 #
Motion for a resolution
Recital E a (new)
Recital E a (new)
Ea. whereas lack of access to effective antibiotics in developing countries still cause more deaths than resistance; whereas AMR is a threat to the achievement of several of the Sustainable Development Goals outlined in Agenda 2030;
Amendment 67 #
Draft opinion
Paragraph 3 a (new)
Paragraph 3 a (new)
3a. Underlines the importance of improvement and dedication of Public Private Partnerships and collaborations between industry, SMEs and public researchers to overcome the scientific challenges of creating new antibiotics, vaccines and diagnostics;
Amendment 68 #
Motion for a resolution
Recital E b (new)
Recital E b (new)
Eb. whereas action to reduce veterinary antimicrobial use has been uneven across EU countries as the latest data from the European Medicine Agency shows1a; whereas some Member States have achieved significant reductions in the use of veterinary antimicrobials over a short period of time thanks to ambitious national policies, as illustrated by a series of fact-finding missions carried out by the European Commission Health and Food Audits and Analysis Directorate1aa; _________________ 1a http://www.ema.europa.eu/ema/index.jsp? curl=pages/news_and_events/news/2017/1 0/news_detail_002827.jsp∣ =WC0b01ac05 8004d5c1antimicrobials 1aa http://ec.europa.eu/food/audits- analysis/audit_reports/index.cfm
Amendment 70 #
Draft opinion
Paragraph 3 b (new)
Paragraph 3 b (new)
3b. Urges the Commission to develop a mission on AMR in the future FP9 with a cross-sectorial and interdisciplinary approach;
Amendment 75 #
Motion for a resolution
Recital E c (new)
Recital E c (new)
Amendment 75 #
Draft opinion
Paragraph 4 a (new)
Paragraph 4 a (new)
4a. Emphasises the need to analyse big data coming from different industry sectors;
Amendment 77 #
Draft opinion
Paragraph 4 b (new)
Paragraph 4 b (new)
4b. Highlights the importance of environmental data in order to have an overview of all aspects affecting AMR;
Amendment 78 #
Draft opinion
Paragraph 4 c (new)
Paragraph 4 c (new)
4c. Underlines the lack of collection of data on the impact on health and socioeconomic burden of AMR on an EU- level and global scale;
Amendment 79 #
Draft opinion
Paragraph 4 d (new)
Paragraph 4 d (new)
Amendment 79 #
Draft opinion
Paragraph 5
Paragraph 5
5. Stresses that disease prevention must be the first step for legislation tackling AMR in agriculture, both to ensure a high standard of animal welfare and reduce the need to resort to antibiotics; believedemands that antibiotics should never be used as compensation for poor hygiene or inadequate animal husbandry;
Amendment 85 #
Draft opinion
Paragraph 5 a (new)
Paragraph 5 a (new)
5a. Calls upon the G7, G20 and BRICS to act and work in close collaboration;
Amendment 86 #
5b. Urges to scale up and combine the numerous international programmes on EU and international level in order to facilitate and support the programmes of European Antimicrobial Resistance Network (EARS-Net), European Surveillance of Antimicrobial Consumption Network (ESAC-Net), Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR), Joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA), ), Institutional Programme for the Prevention and Control of Healthcare Associated Infections and Appropriate Use of Antimicrobials (PIRASAO), WHO Antimicrobial Medicines Consumption Network (AMC), European & Developing Countries Clinical Trials Partnership(EDCTP) and Poverty Related and Neglected Diseases (PRND)1a; _________________ 1a Damage done by Poverty Related and Neglected Diseases within the EU in the year 2015: almost 10.000 Deaths in the EU, 30.000 new HIV infections, mosquito transmitting dengue and chikungunya reported in many parts of Europe. Cf. Global Burden of Disease Results Tool, WHO and European Centre for Disease Prevention and Control.
Amendment 87 #
Draft opinion
Paragraph 6
Paragraph 6
6. Calls on the Commission and the Member States to ensure adequate funding for6. Believes that on-farm investments, such as in quality housing, ventilation, cleaning, disinfection, vaccination and bio-security, probiotics, prebiotics, gen- selection and bio-security must be encouraged and should not be undermined in the future CAP;
Amendment 98 #
Draft opinion
Paragraph 7
Paragraph 7
7. Emphasises the crucial role of education and training programmes, based on the latest scientific developments, in raising awareness about antimicrobial resistance and the prudent use of antimicrobials in veterinary medicine for farmers and those involved in livestock farming;
Amendment 102 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Stresses that the appropriatecorrect and prudent use of antimicrobials is essential to limiting the emergence of AMR in human healthcare, animal husbandry and aquaculture; stresses that there are considerable differences in the way Member States handle and address AMR; calls on the Commission to consider mandatory routine collection and submission of monitoring data at EU level and to establish indictors to measure progress in the fight against AMR;
Amendment 117 #
Motion for a resolution
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Calls on the Commission and Member States to distinguish between livestock and pets particularly in the design of monitoring and assessment of the use of antimicrobials in veterinary medicine, as well as in the design of measures to address their use;
Amendment 118 #
Draft opinion
Paragraph 8
Paragraph 8
8. Underlines the need to change the business culture employed by veterinary medicine producers, which encourages the use and overuse of certain medicines in order to generate profitslosely cooperate with veterinary medicine producers in order to diminish the use of certain medicines with high AMR-Impact; emphasizes that public-private partnerships are essential for the One- Health approach;
Amendment 134 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Calls on the Commission and the Member States to align surveillance, monitoring and reporting of AMR patterns and pathogens; and submit this data to the Global Antimicrobial Resistance Surveillance System (GLASS); furthermore, underlines the utmost importance of systemic collection of all the relevant and comparable data on the volume of sales and the use of veterinary antimicrobial medicinal products, which should be analysed and published by the European Medicine Agency in annual reports; considers that this practice should be made mandatory through European legislation as soon as possible;
Amendment 135 #
Draft opinion
Paragraph 9
Paragraph 9
9. Notes that the use of antibiotics as growth promoters in food-producing animals has been banned in the EU since 2006; calls on the Commission to enforce this ban as a conditionality to all food imports from third countries through Free Trade Agreements;
Amendment 163 #
Motion for a resolution
Paragraph 5 a (new)
Paragraph 5 a (new)
5a. Calls on the Commission to expand its funding to EUCAST who deals with technical aspects of phenotypic in vitro antimicrobial susceptibility testing and functions as the breakpoint committee of EMA and ECDC;
Amendment 171 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Urges Member States to develop ambitious national strategies to tackle AMR in the animal production sector including quantitative reduction targets for the use of veterinary antimicrobials whilst taking local circumstances into account; stresses that all sectors throughout the food chain should be involved in their implementation;
Amendment 177 #
Motion for a resolution
Paragraph 6 b (new)
Paragraph 6 b (new)
6b. Urges the Commission to present a new EU strategy on animal welfare as previously stated by the European Parliament, with the long-term aim of creating an Animal Welfare Law; urges the Commission to implement, without delay, the points outstanding from the European Union Strategy on the Protection and Welfare of Animals 2012- 2015;
Amendment 178 #
Motion for a resolution
Paragraph 6 c (new)
Paragraph 6 c (new)
6c. Calls on the Commission to create a harmonised system for labelling based on animal welfare standards and good animal husbandry practices as already envisaged in 20091a; _________________ 1a https://ec.europa.eu/food/sites/food/files/a nimals/docs/aw_other_aspects_labelling_i p-09-1610_en.pdf
Amendment 225 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Calls on the Commission and the Member States to restrict or stop the sale of antibiotics by those, in line with the 1999 SSC report, eliminate inducements, especially financial, for doctors orand veterinarians whoen prescribe theming antibiotics;
Amendment 246 #
Motion for a resolution
Paragraph 11 a (new)
Paragraph 11 a (new)
11 a. Calls on the Commission to take firm action against the illegal sale of antimicrobial products in the EU;
Amendment 258 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Highlights the value of vaccines, probiotics and prebiotics in combating AMR; recommends integration of targets for life-long vaccination as a key element of national action plans on AMR;
Amendment 275 #
Motion for a resolution
Paragraph 13 a (new)
Paragraph 13 a (new)
Amendment 304 #
Motion for a resolution
Paragraph 14 a (new)
Paragraph 14 a (new)
14 a. Calls on the Commission to consider criteria for combatting AMR in the next review of directive 2014/24/EU on public procurement;
Amendment 327 #
Motion for a resolution
Paragraph 16
Paragraph 16
Amendment 374 #
Motion for a resolution
Paragraph 22
Paragraph 22
22. Notes the hesitant approach of the industry to develop ‘last-line’ antibiotics against bacteria that are resistant to all other antibiotics owing to expected low profitabilityat the business model for developing medicines is not suitable for antibiotic development since resistance can evolve over time and because they are meant to be used as a last resort; calls for incentives for this research and definition of the regulatory pathway;
Amendment 390 #
Motion for a resolution
Paragraph 23
Paragraph 23
23. Calls on the Commission and Member States to work together with the industry to develop new incentive models that delink payment from prescribing volume;